Xu Li-Pu, Qiu Hai-Bo, Yuan Shu-Qiang, Chen Yong-Ming, Zhou Zhi-Wei, Chen Ying-Bo
State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
J Cancer. 2020 Feb 19;11(9):2708-2715. doi: 10.7150/jca.33575. eCollection 2020.
Dysregulation of prostate stem cell antigen (PSCA) has been implicated in human cancers. Studies have reported that PSCA expression is generally high in prostate cancer, which correlates with a worse survival. PSCA is also highly expressed in bladder, ovarian, and pancreatic cancers. However, PSCA is expressed at low levels in gastric, gallbladder and oesophageal cancers. At present, the clinical significance, expression pattern and biological function of PSCA in gastric cancer (GC) are still unclear. Previously, we used cDNA microarray as a screening tool to compare GC tissues with its matched normal gastric mucosa tissues (MNGT), and obtained the differentially expressed genes of the two tissue types. PSCA is one of the genes significantly down-regulated in GC tissues. In this study, we detected the expression of PSCA in GC tissues and MNGT by western-blot experiment and immunohistochemical staining (IHC). Then the relationship between the expression pattern of PSCA and the clinicopathological characteristics and survival in GC was analyzed. In order to further study the function of PSCA in GC, lentivirus was used to construct stable cell lines with knockdown and overexpression of PSCA gene. We used AGS and MKN45 cell lines for plasmid transfection. Colony formation assay, MTS and nude mice xenograft model were performed to investigate the effect of PSCA in GC. Western-blot and IHC assays demonstrated that the expression of PSCA in GC tissues was significantly lower than that in the MNGT. PSCA expression in GC tissues was high in 252 (57.5%) and low in 186 (42.5%) of 438 patients. PSCA expression for MNGT was high in 273 (62.3%) and low in 165 (37.7%) of 438 patients. PSCA expression was significantly associated with T classification (P=0.024), N classification (P=0.018) and TNM stage (P=0.019) using χ test. The relationship between PSCA expression level and patient survival was analysed using Kaplan-Meier analysis and the log-rank test. Low levels of PSCA expression were significantly associated with a poorer OS than high expression levels of PSCA (P=0.011). In the COX regression analysis of OS, all 9 variables in the univariate analysis were significantly correlated with OS (P<0.05), while the variables found to be independently correlated with OS in the multivariate analysis were PSCA expression (P=0.036), age (P<0.001), gender (P=0.007), and TNM stage (P<0.001), respectively. Univariate and multivariate analyses showed that PSCA was an independent prognostic factor for OS in GC. MTS cell proliferation experiment and clonal formation experiment and nude mouse subcutaneous tumorigenesis experiment all proved that knockdown of PSCA gene can improve the proliferation ability of GC cells, while experiment proved that overexpression of PSCA can reduce the proliferation ability of GC cells.It was found that knockdown of PSCA gene can improve the proliferation ability of GC cells both and , while overexpression of PSCA can reduce the proliferation ability of GC cells . Our study showed that the expression of PSCA gene was decreased in GC, which was related to more advanced pathological stages. And the expression level of PSCA in GC was an independent good prognostic factor. PSCA gene had the function of inhibiting GC proliferation.
前列腺干细胞抗原(PSCA)的失调与人类癌症有关。研究报告称,PSCA在前列腺癌中通常高表达,这与较差的生存率相关。PSCA在膀胱癌、卵巢癌和胰腺癌中也高表达。然而,PSCA在胃癌、胆囊癌和食管癌中低表达。目前,PSCA在胃癌(GC)中的临床意义、表达模式和生物学功能仍不清楚。此前,我们使用cDNA微阵列作为筛选工具,比较GC组织与其匹配的正常胃黏膜组织(MNGT),并获得了两种组织类型的差异表达基因。PSCA是GC组织中显著下调的基因之一。在本研究中,我们通过蛋白质免疫印迹实验和免疫组织化学染色(IHC)检测了PSCA在GC组织和MNGT中的表达。然后分析了PSCA的表达模式与GC的临床病理特征及生存率之间的关系。为了进一步研究PSCA在GC中的功能,我们使用慢病毒构建了PSCA基因敲低和过表达的稳定细胞系。我们使用AGS和MKN45细胞系进行质粒转染。进行集落形成试验、MTS试验和裸鼠异种移植模型以研究PSCA在GC中的作用。蛋白质免疫印迹和IHC分析表明,PSCA在GC组织中的表达明显低于MNGT。在438例患者中,252例(57.5%)GC组织中PSCA表达高,186例(42.5%)低。在438例患者中,273例(62.3%)MNGT中PSCA表达高,165例(37.7%)低。使用χ检验,PSCA表达与T分期(P=0.024)、N分期(P=0.018)和TNM分期(P=0.019)显著相关。使用Kaplan-Meier分析和对数秩检验分析PSCA表达水平与患者生存率之间的关系。PSCA低表达水平与高表达水平相比,总生存期(OS)显著较差(P=0.011)。在OS的COX回归分析中,单变量分析中的所有9个变量均与OS显著相关(P<0.05),而多变量分析中发现与OS独立相关的变量分别为PSCA表达(P=0.036)、年龄(P<0.001)、性别(P=0.007)和TNM分期(P<0.001)。单变量和多变量分析表明,PSCA是GC中OS的独立预后因素。MTS细胞增殖实验、克隆形成实验和裸鼠皮下成瘤实验均证明,敲低PSCA基因可提高GC细胞的增殖能力,而过表达PSCA可降低GC细胞的增殖能力。我们的研究表明,PSCA基因在GC中表达降低,这与更晚期的病理阶段相关。并且GC中PSCA的表达水平是一个独立的良好预后因素。PSCA基因具有抑制GC增殖的功能。